Current CollaborationsAktuelle Kooperationen
    Home
    t2cure’s cell therapy is available through cooperating clinical centres
    t2cure cooperates with experienced partners in research and in the industry.
    t2cure's pipeline is built on clinical studies in cardiac and peripheral vascular indications
    t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.

    Current Collaborations

    t2cure cooperates with experienced partners in research institutions and in the industry. New agreements/licencing activities with additional partners are likely to be completed in the near future.